Catalyst Wire Dossier Catalyst Wire Dossier

M2 Macrophage Soluble Factors (intranasal inhalation)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for M2 Macrophage Soluble Factors (intranasal inhalation), covering 2022-05-02 to 2022-05-02. Get the full timeline:

Most recent: Clinical Trial Update: Intranasal Inhalations of M2 Macrophage Soluble Factors in Children With Developmental Speech Disorders [Phase 1, Phase 2]

See pricing